Travere Therapeutics has successfully executed a significant restructuring to recover from previous setbacks and improve its ...

Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal side ...